Q2 2026 AxoGen Inc Earnings Call Transcript

Jul 29, 2026 / 12:00 PM GMT

Transcript 10-Q8-K

Key Points

Positve

Axogen Inc (AXGN) reported a 23% year-over-year revenue growth for the second quarter of 2026, reflecting strong demand across all target markets.
The breast market showed particularly strong growth, contributing approximately two-thirds of the quarter's revenue growth.
The company increased its revenue guidance for the remainder of the year, indicating confidence in its strategic priorities.
Axogen Inc (AXGN) ended the quarter with $113.4 million in cash equivalents, restricted cash, and investments, demonstrating strong financial health.
The company's commercial expansion efforts have been successful, with a total of 172 sales representatives and market development managers, contributing to increased market penetration.

Negative

Gross margin for the quarter was 72.7%, a decrease from 74.2% in the second quarter of 2025, primarily due to product mix changes.
The company faced higher production costs due to the accelerated growth of the breast market, which relies on longer grafts with higher production costs.
Operating expenses increased to $52.8 million in the second quarter, up from $40.3 million in the second quarter of 2025, driven by compensation costs and stock-based compensation expenses.
Net loss for the second quarter was $1.5 million, or $0.03 per share, compared to net income of $0.6 million in the second quarter of 2025.
The company is facing delays in obtaining coverage from Aetna, the largest commercial payer not yet covering its products, which could impact future revenue growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AXGN.OQ - AxoGen Inc
Q2 2026 AxoGen Inc Earnings Call
Jul 29, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone.

Joining me on today's call is Michael Dale, Accident's President and Chief Executive Officer.

And Lindsay Hartley, Chief Financial Officer.

Michael will discuss second quarter 2026 financial results and corporate highlights.

Lindsay will then provide details on financial performance and overall outlook for the year.

This will be followed by a question-and-answer session.

Today's call is.

Today's call and presentation is being broadcast live via webcast, which is available in the investors section of Axygen's website.

Following the end of the live hat, a replay will be available on the investors section of the company's website at www.axogeninc.com.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.